North American Injection Pen Market is Largely Driven by a Large Diabetic Patient Pool

The North American injection pen market is anticipated to grow at a CAGR of 6.2% over the forecast period (2020-2026). The market is primarily driven by the presence of a large pool of diabetic patients in the region. As per the IDF, in North America, the prevalence of diabetes is approximately 13.3% of the total adult population in the region which is projected to reach up to 14.2% by 2030 and further reach up to 15% by 2045. Increased prevalence of diabetes creates demand for insulin pen and hence insulin provides growth opportunities for the market in the forecast period. 

Browse the full report description of "North American Injection Pen Market Size, Share & Trends Analysis Report by Type (Reusable and Disposable), by Disorder Type (Autoimmune Disorder, Hormonal Disorders, Orphan Disease, and Others), and Forecast 2020-2026" at https://www.omrglobal.com/industry-reports/north-american-injection-pen-market

In addition, high awareness amongst the people related to the availability of various treatment products such as advanced insulin pen is further anticipated to contribute to the growth of the market. Further, significant support from governments such as reimbursements for the government and private insurers is readily available within the region which also promotes the growth of the market over the forecast period. 

For instance, there are supportive government initiatives in Canada concerning the awareness about diabetes among Canadians. In June 2019, LMC and Diabetes Canada launched the Canadian Diabetes Prevention Program (CDPP) regarding the awareness of diabetes treatment among the citizens in the country. Hence, such aforementioned factors are likely to support the growth of the market over the forecast period.

Market Coverage

• Market number available for – 2019-2026
• Base year- 2019
• Forecast period- 2020-2026
• Segment Covered- By Type and By Disorder Type 
• Regions Covered- North America 
• Competitive Landscape- Eli Lily & Co., Pfizer Inc., Becton, Dickinson & Co., AstraZeneca Plc, and Novo Nordisk A/S  

Key questions addressed by the report

• What is the market growth rate?
• Which segment dominates the market in the base year?
• Which segment will project the fastest growth in the market?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

North America Injection Pen Market – Segmentation

By Type

• Reusable 
• Disposable 

By Disorder Type

• Autoimmune Disorders
• Hormonal Disorders
• Orphan Diseases
• Others

North America Injection Pen Market – Countries Covered

• United States
• Canada

To learn more about this report request a free sample copy @  https://www.omrglobal.com/request-sample/north-american-injection-pen-market